Benign neoplasm of rectum
ICD-10 D12.8 is a billable code used to indicate a diagnosis of benign neoplasm of rectum.
Benign neoplasms of the rectum are non-cancerous growths that arise from the rectal tissue. These neoplasms can include a variety of histological types, such as adenomas, lipomas, and neurofibromas. While benign, these growths can lead to symptoms such as rectal bleeding, obstruction, or changes in bowel habits, prompting further investigation. Surveillance is essential, as certain types of benign neoplasms, particularly adenomatous polyps, have the potential to progress to colorectal cancer if left untreated. Regular monitoring through colonoscopy is recommended, especially for patients with a history of polyps or familial syndromes that increase the risk of colorectal malignancies. The management of benign rectal neoplasms often involves surgical excision, particularly if they are symptomatic or show signs of dysplasia. Accurate coding of D12.8 is crucial for proper documentation and reimbursement, as it reflects the benign nature of the condition while also indicating the need for surveillance and potential intervention.
Detailed descriptions of the neoplasm type, size, and symptoms, along with surveillance plans.
Patients presenting with rectal bleeding or changes in bowel habits requiring colonoscopy.
Documentation must clearly differentiate between benign and malignant findings to avoid coding errors.
Operative reports detailing the excision of the neoplasm and histopathological findings.
Surgical intervention for symptomatic benign rectal neoplasms.
Ensure that the surgical indication aligns with the diagnosis for accurate coding.
Used for surveillance of benign rectal neoplasms.
Indication for colonoscopy and findings must be documented.
Gastroenterologists should ensure that the reason for the procedure aligns with the diagnosis.
When a biopsy is taken from a benign rectal neoplasm.
Biopsy results must be included in the medical record.
Documentation should specify the type of neoplasm and any follow-up plans.
Coding D12.8 accurately reflects the presence of a benign neoplasm of the rectum, which is important for appropriate management, surveillance, and reimbursement. It also helps differentiate benign conditions from malignant ones, guiding clinical decision-making.
